Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation.

Shares of Apple and Tesla have lost more than 10% since “Liberation Day” during the stock market rollercoaster.

Most physicians surveyed expressed concern that health insurance companies’ use of AI is increasing prior authorization denials.

While not all spending figures are available for the entire 2025 regular session of the General Assembly, which adjourned ...

Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and ...

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...